The main purpose of this study is to evaluate Fetal Medicine Foundation's pre-eclampsia risk calculator using maternal characteristics, first trimester serum placental growth factor (PlGF) and mean arterial pressure (MAP) in a Finnish general population. Condition or disease: pre-eclampsia, intrauterine growth restriction, polycystic ovary syndrome
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Composite of Pregnancy-associated Hypertension and Serious Adverse Outcomes in the Mother or Fetus or Neonate
Timeframe: 20 weeks through discharge following delivery
Severe Hypertension
Timeframe: 20 weeks through discharge following delivery
Severe or Mild Pregnancy-associated Hypertension With Elevated Liver Enzyme Levels
Timeframe: 20 weeks through discharge following delivery
Severe or Mild Pregnancy-associated Hypertension With Thrombocytopenia
Timeframe: 20 weeks through discharge following delivery
Severe or Mild Pregnancy-associated Hypertension With an Elevated Serum Creatinine Level
Timeframe: 20 weeks through discharge following delivery
Severe or Mild Pregnancy-associated Hypertension With an Eclamptic Seizure
Timeframe: 20 weeks through discharge following delivery
Severe or Mild Pregnancy-associated Hypertension With an Indicated Preterm Birth Before 32-34-37 Weeks of Gestation Owing to Hypertension-related Disorders
Timeframe: 20 weeks through discharge following delivery
Severe or Mild Pregnancy-associated Hypertension With a Fetus That Was Small for Gestational Age (Below the - 2 SD) Adjusted for Sex and Race or Ethnic Group
Timeframe: 20 weeks through discharge following delivery
Severe or Mild Pregnancy-associated Hypertension With a Fetal Death After 20 Weeks of Gestation or Neonatal Death
Timeframe: 20 weeks through discharge or prior to discharge following delivery admission
Prevalence of high pre-eclampsia risk score in women with PCOS compared to non-PCOS women
Timeframe: at 13 gestational weeks
11. All the above mentioned outcomes (1-10) in PCOS group compared to non-PCOS group.
Timeframe: 13 gestational weeks through discharge following delivery
The height of the child during the first year of life.
Timeframe: At 0, 3 and 6-12 months of age
The weight of the child during the first year of life.
Timeframe: At 0, 3 and 6-12 months of age
The body mass index (BMI) of the child during the first year of life.
Timeframe: At 0, 3 and 6-12 months of age
Basic blood count
Timeframe: At 0, 3 and 6-12 months of age
Ferritin
Timeframe: At 0, 3 and 6-12 months of age
Hepcidin
Timeframe: At 0, 3 and 6-12 months of age
Saturation of transferrin
Timeframe: At 0, 3 and 6-12 months of age
Hypersensitive-C-reactive protein
Timeframe: At 0, 3 and 6-12 months of age
Anti-mullerian hormone
Timeframe: At 3 and 6-12 months of age
Cortisol
Timeframe: At 3 and 6-12 months of age
Corticotropin
Timeframe: At 3 and 6-12 months of age
Dehydroepiandrosterone
Timeframe: At 3 and 6-12 months of age
Progesterone
Timeframe: At 3 and 6-12 months of age
Inhibin-B
Timeframe: At 3 and 6-12 months of age
Luteinizing hormone
Timeframe: At 3 and 6-12 months of age
Follicle stimulating hormone
Timeframe: At 3 and 6-12 months of age
Testosterone (boys)
Timeframe: At 3 and 6-12 months of age
Estradioli (girls)
Timeframe: At 3 and 6-12 months of age
Vitamin D
Timeframe: At 3 and 6-12 months of age
Calcium
Timeframe: At 3 and 6-12 months of age
Phosphate
Timeframe: At 3 and 6-12 months of age
Alkaline phosphatase
Timeframe: At 3 and 6-12 months of age
Parathyroid hormone
Timeframe: At 3 and 6-12 months of age
Clinical examination of genitals
Timeframe: At 0, 3 and 6-12 months of age
Clinical examination of mammary glands
Timeframe: At 3 and 6-12 months of age
Sebum measurement
Timeframe: At 3 and 6-12 months of age
Heart auscultation with stethoscope.
Timeframe: At 3 and 6-12 months of age
Ultrasound scan of the heart (echo)
Timeframe: At 3 and 6-12 months of age
Birth Weight
Timeframe: At birth
Small for Gestational Age
Timeframe: At birth
Large for gestational age
Timeframe: At birth
Admission to NICU
Timeframe: Delivery through discharge up to 18 weeks
Apgar Score ≤3 at 5 Minutes
Timeframe: At birth
Fetal iron deficiency
Timeframe: At birth
Iron deficiency during third trimester of pregnancy
Timeframe: At 30-32 weeks of gestation
Severe iron deficiency during third trimester of pregnancy
Timeframe: At 30-32 weeks of gestation